Suzette Delaloge

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

Virginie Quidville, Samar Alsafadi, Aïcha Goubar et al. · Cancer Research · 2013 · 107 citations

Life Sciences, Molecular Biology, Oncology +17

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials

Axel Le Cesne, Alejandro Yovine, Jean‐Yves Blay et al. · Investigational New Drugs · 2011 · 77 citations

Medicine, Oncology, Chemotherapy +10

Postoperative radiotherapy in the management of adult soft tissue sarcoma of the extremities: results with two different total dose, fractionation, and overall treatment time schedules

C. Le Péchoux, Marie‐Cécile Le Deley, Suzette Delaloge et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 37 citations

Medicine, Oncology, Radiation Oncology +8